Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vanda Pharmaceuticals (VNDA) Tax Provisions: 2010-2024

Historic Tax Provisions for Vanda Pharmaceuticals (VNDA) over the last 11 years, with Dec 2024 value amounting to -$4.0 million.

  • Vanda Pharmaceuticals' Tax Provisions fell 530.87% to -$5.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$23.0 million, marking a year-over-year decrease of 1245.96%. This contributed to the annual value of -$4.0 million for FY2024, which is 204.99% down from last year.
  • Latest data reveals that Vanda Pharmaceuticals reported Tax Provisions of -$4.0 million as of FY2024, which was down 204.99% from $3.8 million recorded in FY2023.
  • In the past 5 years, Vanda Pharmaceuticals' Tax Provisions ranged from a high of $9.2 million in FY2021 and a low of -$4.0 million during FY2024.
  • For the 3-year period, Vanda Pharmaceuticals' Tax Provisions averaged around $1.6 million, with its median value being $3.8 million (2023).
  • As far as peak fluctuations go, Vanda Pharmaceuticals' Tax Provisions spiked by 109.61% in 2020, and later crashed by 204.99% in 2024.
  • Yearly analysis of 5 years shows Vanda Pharmaceuticals' Tax Provisions stood at $8.3 million in 2020, then increased by 10.75% to $9.2 million in 2021, then slumped by 45.45% to $5.0 million in 2022, then decreased by 23.78% to $3.8 million in 2023, then tumbled by 204.99% to -$4.0 million in 2024.